Risks for ADHD Drugs Outlined in Patient Guides The Food and
Drug Administration has directed manufacturers of medications
approved for the treatment of Attention Deficit Hyperactivity
Disorder (ADHD) to develop Patient Medication Guides that alert
patients about possible risks of cardiovascular and psychiatric
adverse events. Patient Medication Guides are handouts given to
patients, families, and caregivers when a medicine is dispensed.
The guides contain FDA-approved patient information that could
help prevent serious adverse events. People being treated with
ADHD products should read the information before taking the
medication and talk to their doctors if they have any questions
or concerns. An FDA review of serious cardiovascular adverse
events in patients taking usual doses of ADHD products revealed
reports of sudden death in people with underlying serious heart
problems or defects, and reports of stroke and heart attack in
adults with certain risk factors. Another FDA review of ADHD
medicines revealed